BioMarin Pharmaceutical Inc.
BMRN
$52.88
$0.300.57%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 105.53M | -46.57M | -30.74M | 240.53M | 185.69M |
| Total Depreciation and Amortization | 16.41M | 13.04M | 18.49M | 18.56M | 22.07M |
| Total Amortization of Deferred Charges | -- | 7.40M | -- | -- | -- |
| Total Other Non-Cash Items | 59.65M | 289.83M | 262.02M | 84.25M | 57.10M |
| Change in Net Operating Assets | 39.07M | -164.05M | 118.93M | -158.07M | -90.46M |
| Cash from Operations | 220.65M | 99.64M | 368.69M | 185.27M | 174.39M |
| Capital Expenditure | -20.92M | -40.72M | -28.45M | -17.10M | -16.77M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 0.00 | -285.19M | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 746.45M | -1.73M | -17.32M | 4.51M | -11.47M |
| Cash from Investing | 725.53M | -42.45M | -330.96M | -12.59M | -28.24M |
| Total Debt Issued | 850.00M | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 6.75M | 7.00K | 7.71M | -- |
| Repurchase of Common Stock | -28.18M | -2.70M | -2.18M | -12.31M | -38.78M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -8.65M | -889.00K | -- | -- | -- |
| Cash from Financing | 813.17M | 3.16M | -2.17M | -4.60M | -38.78M |
| Foreign Exchange rate Adjustments | 1.41M | 1.22M | 739.00K | -3.06M | -1.42M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.76B | 61.57M | 36.29M | 165.01M | 105.96M |